Navigation Links
First Warning Systems and Unicorp Biotech International Strategic Partner Letter of Intent Signed Breast Cancer Early Detection
Date:12/12/2012

RENO, Nev., Dec. 12, 2012 /PRNewswire/ -- First Warning Systems, Inc. announced a Letter of Intent with Budapest, Hungary, European Union based medical products marketing partner, UniCorp Biotech. "We look forward to productive developments regarding the regulatory advise, marketing and distribution resources of UniCorp Biotech", says Jim Holmes, Chairman and CEO of First Waning Systems. "The Letter of Intent outlines a mutually beneficial process for defining how the capabilities of UniCorp Biotech can partner with First Warning", adds Dr. Laszlo Horvath, CEO.

"We are planning for the CE Mark process early in 2013 to be followed by clinical validation and market entry of the First Warning Systems in select European markets", says Matt Benardis, First Warning Operations Manager. "Discussions with Dr. Horvath regarding UniCorp Biotech services to expedite certification and time-to-market have been encouraging", adds Benardis.

About First Warning Systems Process
Temperature readings of breast tissue create a dynamic cell chaos profile using 9,600 points of dynamic data which are correlated to dysfunctional circadian genes. Multiple bioinformatics algorithms compare the circadian gene protein profiles to identify breast tissue abnormalities at different stages of development of disturbed breast cancerous cells. FWS delivers a report to the primary care physician with industry leading 90% accuracy. The FWS process is the only detection process that identifies abnormalities before a tumor presents and can be used by a primary care physician.

About First Warning Systems
First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS's principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO). FWS holds the exclusive development, manufacturing and marketing worldwide license from Lifeline, to commercialize the intellectual property. The FWS product line is a device and process that detects breast tissue abnormalities leading to health risk assessment and management and potentially, breast cancer. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. FWS is preparing to apply for a Euro CE Mark to market in the UK, EU and Russia markets. See FWS' video, "Breast Cancer Tumor Progression" at www.firstwarningsystems.com. For more information, contact: Abbi Whittaker, The Abbi Agency. (775) 323-2977, abbi@theabbiagency.com

About Unicorp Biotech
UniCorp Biotech was founded at the turn of the century. The owners desire to play a key role in the changing health care system of Europe in the area of quick and easy home access. Our company also manages (preparations, ethical permissions, monitoring) CRO projects within and outside of the European Union. We have the privilege to welcome among our customers many multinational companies acting in health care and distribution, such as Merck-Serono, Alexion, Gedeon Richter, PhamaNord, PhoenixPharma, HungaroPharma, Krka, Yamanouchi, Pliva, Tesco, Rossmann, Schlecker, Hungarian Military, National Police Headquarters. Our products are available in most pharmacies throughout Hungary and in some CEE countries. Since January of 2006, we have been the official Hungarian representatives of the Berlin-based Bayer Dermatology. UniCorp Biotech also provides information and preventive help for women, infants and Hungarians needing to be more informed, www.infertility.hu. & www.feminin.hu & www.abstinentia.hu provide assistance to those dealing with drug or other dependencies. For more information, contact: Dr. Laszlo Horvath, CEO, UniCorp Biotech Kft, H-1126 Budapest, Toth Lorincu.41., Hungary, Tel.: +36-1-393-5050, Fax: +36-1-393-5055.


'/>"/>
SOURCE First Warning Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. First Suit Against Nobel Prize Organization Citing Defamation And Unfair Competition Practices Is Filed
2. Topokine Announces Dosing of First Subject in a Phase I Clinical Trial of XAF5 Gel for Local Reduction of Subcutaneous Fat
3. Karmanos Cancer Center first in Midwest to offer latest Molecular Breast Imaging
4. China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2013
5. First Effective Treatment For Traumatic Brain Injury Reported by Institute of Neurological Recovery, Even Years After Injury
6. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2013 Results; Teleconference and Webcast to be held on November 14, 2012
7. First noiseless single photon amplifier
8. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2013 Financial Results
9. Elektas Monaco System Used for First Time to Create VMAT Plan for Delivery on Varian Treatment System
10. Palatin Technologies, Inc. To Report Fiscal Year 2013 First Quarter Results; Teleconference and Webcast to be held on November 14, 2012
11. First Neurally Controlled, Powered Prosthetic Limb Is 2,109 Steps Closer To Realization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Houston Methodist ... the Cy-Fair Sports Association to serve as their ... agreement, Houston Methodist Willowbrook will provide sponsorship support, ... connectivity with association coaches, volunteers, athletes and families. ... the Cy-Fair Sports Association and to bring Houston ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... ON (PRWEB) , ... June 23, 2016 , ... STACS ... DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as ... the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
Breaking Biology News(10 mins):